|
Nanoplatforms | Drug | Company | Properties | Indications | Routes of administration |
|
Liposomes | Abelcet | Enzon | Liposomal amphotericin B | Fungal infections | i.v. |
AmBisome | Gilead Sciences | Liposomal amphotericin B | Fungal and protozoal infections | i.v. |
Amphotec | Three Rivers Pharmaceuticals | Cholesteryl sulfate-based amphotericin B | Fungal infections | i.v. |
DepoCyt | SkyePharma | Liposomal cytarabine | Malignant lymphomatous meningitis | i.t. |
DaunoXome | Gilead Sciences | Liposomal daunorubicin | HIV-related Kaposi’s sarcoma | i.v. |
Doxil/Caelyx | Ortho Biotech, Schering-Plough | Liposome-PEG doxorubicin | HIV-related Kaposi’s sarcoma, metastatic breast cancer, and metastatic ovarian cancer | i.m. |
Myocet | Zeneus | Liposomal doxorubicin | Combination therapy with cyclophosphamide in metastatic breast cancer | i.v. |
Visudyne | QLT, Novartis | Liposomal verteporfin | Photodynamic therapy (PDT) for age-related macular degeneration, pathologic myopia, and ocular histoplasmosis | i.v. |
|
Polymers | Adagen | Enzon | PEG-adenosine deaminase | Severe combined immunodeficiency disease associated with ADA deficiency | i.m. |
Copaxone | TEVA Pharmaceuticals | L-Glutamic acid, L-alanine, L-lysine, and L-tyrosine copolymer | Multiple sclerosis | s.c. |
Genexol-PM | Samyang | Methoxy-PEG-poly(D, L-lactide) paclitaxel | Metastatic breast cancer | i.v. |
Macugen | OSI Pharmaceuticals | PEG-anti-VEGF aptamer | Age-related macular degeneration | i.r. |
Neulasta | Amgen | PEG-GCSF | Neutropenia associated with cancer Chemotherapy | s.c. |
Oncaspar | Enzon | Pegaspargase (PEG-L-asparaginase) | Acute lymphoblastic leukemia | i.v., i.m. |
Renagel | Genzyme | Poly(allylamine hydrochloride) | End-stage renal disease | Oral |
Somavert | Nektar, Pfizer | PEG-HGF | Acromegaly | s.c. |
|
Others | Abraxane | Abraxis BioScience, AstraZeneca | Albumin-bound paclitaxel | Metastatic breast cancer | i.v. |
Estrasorb | Novavax | Estradiol emulsion | Vasomotot symptoms associated with menopause | Topical and transdermal |
Emend | Elan, Merck | Nanocrystalline aprepitant | Antiemetic | Oral |
Megace ES | Strativa Pharmaceuticals, subsidiary of Par Pharmaceutical. Inc. | Nanocrystalline megestrol acetate | Anorexia, cachexia, or an unexplained significant weight loss in AIDS patients | Oral |
Rapamune | Elan, Wyeth Pharmaceuticals | Nanocrystalline sirolimus | Immunosuppressant | Oral |
TriCor | Elan, Abbott | Nanocrystalline fenofibrate | Antihyperlipidemic | Oral |
Feridex | Bayer Healthcare Pharmaceuticals |
Femmoxides solution (superparamagnetic iron oxide) | MRI contrast agent | i.v. |
|